← back to search

Douglas B. Cines

Weill Cornell Medicine · US
Area of research
Hematology · Surgery
Research interest
Research interests include Platelet Disorders and Treatments, Heparin-Induced Thrombocytopenia and Thrombosis, Blood Coagulation and Thrombosis Mechanisms, and Protease and Inhibitor Mechanisms.
h-index
86
citations
33,255
works
478
NIH funding
primary concept
Medicine
email

Recent publications

Neonatal Fc Receptor — Biology and Therapeutics
New England Journal of Medicine 2025cited by 26position: middledoi
Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia.
2025cited by 4position: contributordoi
PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension
American Journal of Physiology-Lung Cellular and Molecular Physiology 2024cited by 8position: middledoi
Packaging of supplemented urokinase into alpha granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.
2024cited by 3position: contributordoi
Vaccine-induced immune thrombotic thrombocytopenia.
2023cited by 45position: contributordoi
Management of Primary Immune Thrombocytopenia in Pregnancy
New England Journal of Medicine 2023cited by 31position: lastdoi
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
2023cited by 9position: contributordoi
Pathogenesis of refractory ITP: Overview.
2023cited by 8position: contributordoi
Neutrophil extracellular trap stabilization by platelet factor 4 reduces thrombogenicity and endothelial cell injury
2023cited by 1position: contributordoi
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
2022cited by 58position: contributordoi
Human neutrophil peptides 1-3 protect the murine urinary tract from uropathogenic <i>Escherichia coli</i> challenge.
2022cited by 14position: contributordoi
Minimal role for the alternative pathway in complement activation by HIT immune complexes.
2022cited by 6position: contributordoi
Platelets get particular.
2022cited by 0position: contributordoi
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
New England Journal of Medicine 2021cited by 517position: firstdoi
Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination
American Journal of Hematology 2021cited by 387position: middledoi
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Blood 2021cited by 70position: middledoi
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.
2021cited by 29position: contributordoi
Alpha‐defensins: risk factor for thrombosis in COVID‐19 infection
British Journal of Haematology 2021cited by 19position: middledoi
Divergent impacts of tocilizumab and colchicine in COVID‐19‐associated coagulopathy: the role of alpha‐defensins
British Journal of Haematology 2021cited by 6position: middledoi
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation
Blood 2020cited by 71position: contributordoi
COVID-19-associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype?
2020cited by 39position: contributordoi
FcRn augments induction of tissue factor activity by IgG-containing immune complexes
Blood 2020cited by 33position: contributordoi
Opposing effects of HNP1 (α-defensin-1) on plasma cholesterol and atherogenesis
PLoS ONE 2020cited by 16position: middledoi
Diagnosing HIT: the need for speed
Blood 2020cited by 6position: contributordoi
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Blood Advances 2019cited by 1,311position: middledoi
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Blood Advances 2019cited by 1,163position: contributordoi
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia
Journal of Thrombosis and Haemostasis 2019cited by 67position: middledoi
Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK.
2019cited by 47position: contributordoi
Human neutrophil peptide‐1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols
Journal of Thrombosis and Haemostasis 2019cited by 15position: middledoi
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Blood Advances 2018cited by 704position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 16 papers (2019–2025)Lubica Rauova · Philadelphia University9 papers (2015–2025) · 8 papers (2020–2025)Mortimer Poncz · Philadelphia University8 papers (2012–2024)Khalil Bdeir · University of Tübingen7 papers (2016–2021)James B. Bussel · Cornell University7 papers (2012–2025)X. Long Zheng · University of Alabama at Birmingham6 papers (2015–2019)Abd Al‐Roof Higazi · Hebrew University of Jerusalem6 papers (2015–2021)Rami Abu‐Fanne · Technion – Israel Institute of Technology5 papers (2015–2021)Gowthami M. Arepally · Duke University5 papers (2018–2023)Suhair Abdeen · Hebrew University of Jerusalem5 papers (2015–2021)Emad Maraga · Hebrew University of Jerusalem5 papers (2015–2021)Mohamed Higazi · Hebrew University of Jerusalem4 papers (2018–2021)Adam Cuker · Pennsylvania Hospital4 papers (2018–2021)С. В. Зайцев · Lomonosov Moscow State University3 papers (2012–2024) · 3 papers (2020–2024)Sanjay Khandelwal · Duke University3 papers (2021–2023) · 3 papers (2021–2023)Don L. Siegel · Abramson Cancer Center3 papers (2015–2016)Nichola Cooper · Imperial College Healthcare NHS Trust3 papers (2013–2019)